Dawn Parsell Otto, EVP, Clinical Development at Tricida, Inc. (TCDA), sold 5,471 shares at $31.98 ($172K) on 2020-04-29, disclosed to the SEC on 2020-04-30.
Open-market sale of $172k TCDA by EVP, Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.98 | 1,250 | $37K | 21.7% |
| 2 | $31.98 | 210 | $7K | 3.9% |
| 3 | $31.98 | 523 | $17K | 9.7% |
| 4 | $31.98 | 1,744 | $56K | 32.3% |
| 5 | $31.98 | 1,744 | $56K | 32.3% |
| Total | $31.52 avg | 5,471 |
| $172K |
| 100% |
| Filing → |
| TCDA | SELL | 2020-03-04 | $214K | — | Filing → |
| TCDA | SELL | 2020-02-05 | $242K | — | Filing → |
| TCDA | SELL | 2020-01-06 | $227K | — | Filing → |